SILTUXIMAB | B125496 | RECORDATI RARE DISEASES, INC.
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | Apr. 23, 2026 | Expired | Computed |
| 7-Year Orphan | Apr. 23, 2021 | Expired | Purple Book |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12303483(formulation) · relevance 55/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
14 AI-discovered patents, sorted by relevance.
No patent or exclusivity listings for this strength.